Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Gemcitabine|DRUG: Epirubicin|DRUG: Albumin-bound Paclitaxel
Sponsor: SCRI Development Innovations, LLC
Collaborators: Eli Lilly and Company|Celgene Corporation